vs
HECLA MINING CO（HL）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是HECLA MINING CO的1.7倍（$772.1M vs $448.1M），HECLA MINING CO净利率更高（30.0% vs 12.7%，领先17.3%），HECLA MINING CO同比增速更快（79.5% vs 5.9%），Revvity自由现金流更多（$161.8M vs $134.7M），过去两年HECLA MINING CO的营收复合增速更高（53.8% vs 9.0%）
赫克拉矿业是总部位于美国的金属开采企业，主营银、金、铅、锌等矿产开发，矿区主要分布于北美地区，产品供应珠宝、工业制造、新能源供应链等领域，是美国头部原生银生产商之一。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
HL vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.7倍
$448.1M
营收增速更快
HL
高出73.6%
5.9%
净利率更高
HL
高出17.3%
12.7%
自由现金流更多
RVTY
多$27.1M
$134.7M
两年增速更快
HL
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $448.1M | $772.1M |
| 净利润 | $134.4M | $98.4M |
| 毛利率 | 55.4% | — |
| 营业利润率 | 49.1% | 14.5% |
| 净利率 | 30.0% | 12.7% |
| 营收同比 | 79.5% | 5.9% |
| 净利润同比 | 1027.2% | 3.9% |
| 每股收益（稀释后） | $0.20 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HLRVTY
| Q4 25 | $448.1M | $772.1M | ||
| Q3 25 | $409.5M | $698.9M | ||
| Q2 25 | $304.0M | $720.3M | ||
| Q1 25 | $261.3M | $664.8M | ||
| Q4 24 | $249.7M | $729.4M | ||
| Q3 24 | $245.1M | $684.0M | ||
| Q2 24 | $245.7M | $691.7M | ||
| Q1 24 | $189.5M | $649.9M |
净利润HLRVTY
| Q4 25 | $134.4M | $98.4M | ||
| Q3 25 | $100.7M | $46.7M | ||
| Q2 25 | $57.7M | $53.9M | ||
| Q1 25 | $28.9M | $42.2M | ||
| Q4 24 | $11.9M | $94.6M | ||
| Q3 24 | $1.8M | $94.4M | ||
| Q2 24 | $27.9M | $55.4M | ||
| Q1 24 | $-5.8M | $26.0M |
毛利率HLRVTY
| Q4 25 | 55.4% | — | ||
| Q3 25 | 44.1% | 53.6% | ||
| Q2 25 | 39.3% | 54.5% | ||
| Q1 25 | 28.3% | 56.5% | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 24.2% | 56.3% | ||
| Q2 24 | 20.9% | 55.7% | ||
| Q1 24 | 10.1% | 54.6% |
营业利润率HLRVTY
| Q4 25 | 49.1% | 14.5% | ||
| Q3 25 | 36.3% | 11.7% | ||
| Q2 25 | 30.8% | 12.6% | ||
| Q1 25 | 20.0% | 10.9% | ||
| Q4 24 | 15.3% | 16.3% | ||
| Q3 24 | 9.2% | 14.3% | ||
| Q2 24 | 16.5% | 12.4% | ||
| Q1 24 | 2.7% | 6.8% |
净利率HLRVTY
| Q4 25 | 30.0% | 12.7% | ||
| Q3 25 | 24.6% | 6.7% | ||
| Q2 25 | 19.0% | 7.5% | ||
| Q1 25 | 11.0% | 6.4% | ||
| Q4 24 | 4.8% | 13.0% | ||
| Q3 24 | 0.7% | 13.8% | ||
| Q2 24 | 11.3% | 8.0% | ||
| Q1 24 | -3.0% | 4.0% |
每股收益（稀释后）HLRVTY
| Q4 25 | $0.20 | $0.86 | ||
| Q3 25 | $0.15 | $0.40 | ||
| Q2 25 | $0.09 | $0.46 | ||
| Q1 25 | $0.05 | $0.35 | ||
| Q4 24 | $0.03 | $0.77 | ||
| Q3 24 | $0.00 | $0.77 | ||
| Q2 24 | $0.04 | $0.45 | ||
| Q1 24 | $-0.01 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $301.2M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.6B | $7.3B |
| 总资产 | $3.6B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HLRVTY
| Q4 25 | $301.2M | $919.9M | ||
| Q3 25 | $133.9M | $931.4M | ||
| Q2 25 | $296.6M | $991.8M | ||
| Q1 25 | $23.7M | $1.1B | ||
| Q4 24 | $26.9M | $1.2B | ||
| Q3 24 | $22.3M | $1.2B | ||
| Q2 24 | $24.6M | $2.0B | ||
| Q1 24 | $80.2M | $1.7B |
股东权益HLRVTY
| Q4 25 | $2.6B | $7.3B | ||
| Q3 25 | $2.4B | $7.4B | ||
| Q2 25 | $2.3B | $7.6B | ||
| Q1 25 | $2.1B | $7.6B | ||
| Q4 24 | $2.0B | $7.7B | ||
| Q3 24 | $2.0B | $7.9B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.0B | $7.8B |
总资产HLRVTY
| Q4 25 | $3.6B | $12.2B | ||
| Q3 25 | $3.2B | $12.1B | ||
| Q2 25 | $3.3B | $12.4B | ||
| Q1 25 | $3.0B | $12.4B | ||
| Q4 24 | $3.0B | $12.4B | ||
| Q3 24 | $3.0B | $12.8B | ||
| Q2 24 | $2.9B | $13.4B | ||
| Q1 24 | $3.0B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $217.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $134.7M | $161.8M |
| 自由现金流率自由现金流/营收 | 30.1% | 21.0% |
| 资本支出强度资本支出/营收 | 18.4% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.61× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $310.2M | $509.4M |
8季度趋势，按日历期对齐
经营现金流HLRVTY
| Q4 25 | $217.1M | $182.0M | ||
| Q3 25 | $148.0M | $138.5M | ||
| Q2 25 | $161.8M | $134.3M | ||
| Q1 25 | $35.7M | $128.2M | ||
| Q4 24 | $67.5M | $174.2M | ||
| Q3 24 | $55.0M | $147.9M | ||
| Q2 24 | $78.7M | $158.6M | ||
| Q1 24 | $17.1M | $147.6M |
自由现金流HLRVTY
| Q4 25 | $134.7M | $161.8M | ||
| Q3 25 | $90.1M | $120.0M | ||
| Q2 25 | $103.8M | $115.5M | ||
| Q1 25 | $-18.4M | $112.2M | ||
| Q4 24 | $6.7M | $149.8M | ||
| Q3 24 | $-690.0K | $125.6M | ||
| Q2 24 | $28.3M | $136.6M | ||
| Q1 24 | $-30.5M | $129.7M |
自由现金流率HLRVTY
| Q4 25 | 30.1% | 21.0% | ||
| Q3 25 | 22.0% | 17.2% | ||
| Q2 25 | 34.1% | 16.0% | ||
| Q1 25 | -7.0% | 16.9% | ||
| Q4 24 | 2.7% | 20.5% | ||
| Q3 24 | -0.3% | 18.4% | ||
| Q2 24 | 11.5% | 19.7% | ||
| Q1 24 | -16.1% | 20.0% |
资本支出强度HLRVTY
| Q4 25 | 18.4% | 2.6% | ||
| Q3 25 | 14.1% | 2.6% | ||
| Q2 25 | 19.1% | 2.6% | ||
| Q1 25 | 20.7% | 2.4% | ||
| Q4 24 | 24.3% | 3.4% | ||
| Q3 24 | 22.7% | 3.3% | ||
| Q2 24 | 20.5% | 3.2% | ||
| Q1 24 | 25.1% | 2.7% |
现金转化率HLRVTY
| Q4 25 | 1.61× | 1.85× | ||
| Q3 25 | 1.47× | 2.97× | ||
| Q2 25 | 2.80× | 2.49× | ||
| Q1 25 | 1.24× | 3.03× | ||
| Q4 24 | 5.66× | 1.84× | ||
| Q3 24 | 31.24× | 1.57× | ||
| Q2 24 | 2.82× | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HL
| Silver Contracts | $258.5M | 58% |
| Gold | $129.2M | 29% |
| Zinc | $30.3M | 7% |
| Lead | $23.3M | 5% |
| Environmental Remediation Services | $9.2M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
